Stock Research: TELA Bio

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

TELA Bio

NasdaqGM:TELA US8723811084
42
  • Value
    36
  • Growth
    58
  • Safety
    Safety
    57
  • Combined
    47
  • Sentiment
    41
  • 360° View
    360° View
    42
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

TELA Bio, Inc. is a medical technology company providing soft-tissue reconstruction solutions for hernia repair, abdominal wall reconstruction, and plastic/reconstructive surgery with products like OviTex and OviTex PRS. In the last fiscal year, the company had 209 employees, a market cap of $81 million, profits of $46 million, and revenue of $69 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock TELA Bio are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for TELA Bio. The consolidated Value Rank has an attractive rank of 57, which means that the share price of TELA Bio is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 57% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 58, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 41. Professional investors are more confident in 59% other stocks. Worryingly, the company has risky financing, with a Safety rank of 36. This means 64% of comparable companies have a safer financing structure than TELA Bio. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 81 47 47
Growth
58 65 47 55
Safety
Safety
36 19 42 58
Sentiment
41 49 49 80
360° View
360° View
42 72 40 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
74 83 71 86
Opinions Change
50 50 50 13
Pro Holdings
n/a 22 14 67
Market Pulse
36 48 78 79
Sentiment
41 49 49 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 81 47 47
Growth
58 65 47 55
Safety Safety
36 19 42 58
Combined
47 70 34 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
36 36 36 36
Price vs. Earnings (P/E)
95 78 67 58
Price vs. Book (P/B)
25 100 37 26
Dividend Yield
1 1 1 1
Value
57 81 47 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
90 90 77 87
Profit Growth
34 71 41 41
Capital Growth
86 65 85 41
Stock Returns
10 11 23 51
Growth
58 65 47 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
15 12 6 32
Refinancing
90 63 79 75
Liquidity
29 43 52 42
Safety Safety
36 19 42 58

Similar Stocks

Discover high‑ranked alternatives to TELA Bio and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.